A detailed history of Foundations Investment Advisors, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Foundations Investment Advisors, LLC holds 15,087 shares of BMY stock, worth $870,218. This represents 0.02% of its overall portfolio holdings.

Number of Shares
15,087
Previous 70,239 78.52%
Holding current value
$870,218
Previous $2.92 Million 73.26%
% of portfolio
0.02%
Previous 0.08%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 21, 2024

SELL
$39.66 - $51.75 $2.19 Million - $2.85 Million
-55,152 Reduced 78.52%
15,087 $780,000
Q2 2024

Aug 02, 2024

BUY
$40.25 - $52.99 $399,843 - $526,402
9,934 Added 16.47%
70,239 $2.92 Million
Q1 2024

May 13, 2024

BUY
$47.98 - $54.4 $85,932 - $97,430
1,791 Added 3.06%
60,305 $3.27 Million
Q4 2023

Feb 08, 2024

BUY
$48.48 - $57.85 $257,671 - $307,472
5,315 Added 9.99%
58,514 $3 Million
Q3 2023

Oct 05, 2023

BUY
$57.89 - $64.73 $372,580 - $416,602
6,436 Added 13.76%
53,199 $3.09 Million
Q2 2023

Jul 19, 2023

SELL
$63.71 - $70.74 $298,353 - $331,275
-4,683 Reduced 9.1%
46,763 $2.99 Million
Q1 2023

Apr 25, 2023

BUY
$65.71 - $74.53 $972,507 - $1.1 Million
14,800 Added 40.39%
51,446 $3.57 Million
Q4 2022

Jan 11, 2023

BUY
$68.48 - $81.09 $1.52 Million - $1.8 Million
22,209 Added 153.83%
36,646 $0
Q3 2022

Oct 19, 2022

BUY
$0.13 - $76.84 $574 - $339,555
4,419 Added 44.11%
14,437 $1.03 Million
Q2 2022

Jul 08, 2022

BUY
$72.62 - $79.98 $425,044 - $468,122
5,853 Added 140.53%
10,018 $764,000
Q1 2022

Apr 19, 2022

SELL
$61.48 - $73.72 $37,133 - $44,526
-604 Reduced 12.67%
4,165 $323,000
Q4 2021

Jan 21, 2022

SELL
$53.63 - $62.52 $4,344 - $5,064
-81 Reduced 1.67%
4,769 $309,000
Q3 2021

Oct 13, 2021

BUY
$59.17 - $69.31 $10,177 - $11,921
172 Added 3.68%
4,850 $287,000
Q2 2021

Jul 14, 2021

BUY
$61.91 - $67.42 $289,614 - $315,390
4,678 New
4,678 $314,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Foundations Investment Advisors, LLC Portfolio

Follow Foundations Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Foundations Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Foundations Investment Advisors, LLC with notifications on news.